关于临床前阿尔茨海默病模型的全面审查:评估其临床相关性
Virendra Kushwaha1, Kantrol Kumar Sahu1
1Institute of Pharmaceutical Research, GLA University, Mathura, UP, 281406, India.
Current pharmaceutical biotechnology
|August 20, 2024
概括
阿尔茨海默氏病 (AD) 研究依赖于实验模型来了解病变发生和测试治疗方法. 本综述详细介绍了各种AD模型的优缺点,包括细胞培养和动物模型,以改善治疗开发.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 生物医学研究生物医学研究
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经系统疾病,其特征是神经纤维质团和粉样质斑块.
- 由于预期寿命的增加,阿尔茨海默病的发病率在全球范围内不断增加,迫切需要进行研究和有效治疗.
- 实验模型对于理解AD病原和评估潜在治疗干预措施至关重要.
研究的目的:
- 审查和分析目前阿尔茨海默病实验模型的致病特征和局限性.
- 评估各种模型的有用性,包括转基因动物和体外系统,在AD研究中.
- 为改善临床前发现转化为临床应用提供见解.
主要方法:
- 在阿尔茨海默病研究中使用的实验模型的综合文献综述.
- 对转基因小鼠,大鼠,灵长类动物,非灵长类动物模型和人类体外细胞培养的病原特征和局限性的分析.
- 讨论共患病模型的潜力和AD实验建模的未来方向.
主要成果:
- 没有一个单一的实验模型能够完全复制人类阿尔茨海默病的所有方面.
- 每个模型 (转基因动物,细胞培养) 都提供了对特定AD病理和机制的部分见解.
- 了解不同模型的优缺点是有效治疗开发的关键.
结论:
- 尽管有局限性,但实验模型是促进阿尔茨海默病研究不可或缺的工具.
- 利用多种模型,更深入地了解它们各自的优缺点,可以提高治疗翻译的效果.
- 未来的研究应该探索新的建模方法,包括共患病模型,以更好地回顾AD复杂性.
相关概念视频
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Alzheimer's Disease: Treatment
171
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
171


